Be the first person to write a business review for Amplifon S.p.A.

In 1999 Amplifon USA was established to manage and grow Miracle-Ear®, one of the oldest and most recognized brands in the hearing aid industry. Founded in 1948, Miracle-Ear dispenses hearing aids and services at more than 1,000 locations, many of which are located in Sears stores. In October, 2002, North America’s largest group of hearing aid and service providers, Sonus®, joined the Amplifon USA family. Founded in 1993 in Portland, Oregon, Sonus augmented the organization with 87 company-owned clinics in the U.S. and Canada, as well as a network of approximately 1,400 affiliated members.Amplifon USA's Headquarters in Plymouth Minnesota Growth for Amplifon USA continued in 2003 with the addition of National Hearing Centers, a hearing aid retailer with more than 50 centers. National Hearing Centers changed its name to Amplifon® Hearing Aid Centers in 2006. Most of the Amplifon Hearing Aid Centers are located in Wal-Mart stores or Wal-Mart Super Centers, providing Amplifon USA with access to the world’s largest retail organization. HearPO®, founded in 1995 and acquired by Sonus in 1998 and now a member of the Amplifon USA family, is the largest provider of hearing health care benefits in the United States, providing products and services through a network of over 1,600 credentialed clinics. Their customized programs provide coverage for organizations, employers, third party administrators and government agencies.

Based in the UK, Andersen Products Ltd. was established in 1973 and is the Andersen Global Group’s headquarters for the sales and distribution of Ethylene Oxide sterilisers and associated products to Europe, the Middle East and Africa. Our commitment to product research and development means that we can offer both our existing and our new clients a prompt and innovative sterilisation solution, tailor-made to meet their individual requirements. This dedication is reinforced by providing our with clients ongoing support and training for the life of their steriliser.

Angeion Corporation, through its subsidiary, Medical Graphics Corporation, develops, manufactures, and markets non-invasive cardio-respiratory diagnostic systems. Angeion Corporation company’s primary products include pulmonary function and cardiopulmonary exercise testing systems. Its pulmonary function systems are classified into three product categories: Spirometry, Complete Pulmonary Function, and Body Plethysmography. Applications of these products include evaluating the effect of medication; monitoring patients with chronic disease; diagnosing lung diseases, such as chronic obstructive pulmonary disease, asthma, and emphysema; managing treatment; assessing the surgical risk of lung transplant and lung reduction candidates; and evaluating the impact of diseases, such as neuromuscular disease on breathing. Angeion Corporation company’s cardiopulmonary exercise testing systems measure functional capacity, fitness, or conditioning levels, as well as help physicians diagnose heart and lung diseases. The cardiopulmonary exercise testing systems are used in various applications consisting of distinguishing between cardiovascular and pulmonary disease, screening for early signs of cardiac and pulmonary dysfunction, establishing exercise prescriptions and training programs, and evaluating the efficacy of prescribed therapy. Angeion Corporation also offers cycle ergometer, a specially-designed stationary exercise bicycle that provides healthcare professionals and patients a tool for clinical rehabilitation and athletic training. Angeion Corporation markets its products under the MedGraphics and New Leaf brand names. Angeion Corporation serves hospitals, university-based medical centers, medical clinics, physician offices, health and fitness clubs, weight loss clinics, and personal training studios. It markets its products through direct sales force in the United States; and through a network of independent distributors internationally. Angeion Corporation was founded in 1986 and is based in Saint Paul, Minnesota.

Founded in 1988 in Queensbury, N.Y., U.S., AngioDynamics is today a NASDAQ-listed public company. We are a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease. Our diverse product line includes market-leading radiofrequency ablation and irreversible electroporation resection systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products.AngioDynamics has distinguished itself as a dynamic brand in a technologically competitive, high-growth industry, through the company’s consistent ability to successfully develop and bring to market new technologies and products. AngioDynamics believes it is well poised to continue that trend. Looking into the future, the company plans to bring forth a continuing stream of innovations that greatly improve patient care by providing the highest-quality, best-performing products.

Antares Pharma, Inc., a pharmaceutical company, focuses on self-injection pharmaceutical products and technologies, and topical gel-based products. It offers injection devices, which include Medi-Jector Vision for insulin; Zomajet 2 Vision, Zomajet Vision X, Twin-Jector EZ II, and Tjet for human growth hormone; Vibex pressure assisted auto injector platform that enables a controlled pressure delivery of drugs into the body utilizing a spring power source; and disposable pen injectors, which are needle-based devices designed to deliver multiple injections from multi-dose drug cartridges. Antares Pharma also develops/commercializes Anturol, an oxybutynin ATD (advanced transdermal delivery)gel, which is in Phase III clinical trials for the treatment of overactive bladder; Elestrin, a transdermal estradiol gel for the treatment of moderate-to-severe vasomotor symptoms associated with menopause; LibiGel, a transdermal testosterone gel that is in Phase III clinical studies for the treatment of female sexual dysfunction; Nestorone contraceptive formulation products, which has completed Phase II clinical trials; and Ropinerole to treat a central nervous system. Antares Pharma, Inc. markets its products to pharmaceutical companies primarily in the United States and Europe. It has collaborative arrangements and license agreements primarily with Teva Pharmaceutical Industries, Ltd.; BioSante Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Population Council, Ferring Pharmaceuticals BV; Eli Lilly and Company; JCR Pharmaceuticals Co., Ltd.; and Solvay Pharmaceuticals BV, as well as a strategic alliance with Uman Pharma. Antares Pharma, Inc. was formerly known as Medi-Ject Corporation and changed its name to Antares Pharma, Inc. in January 2001. Antares Pharma, Inc. was founded in 1979 and is based in Ewing, New Jersey.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.